Skip to main content
. 2016 Jul 13;11(7):e0157514. doi: 10.1371/journal.pone.0157514

Table 7. Results for predicting conversion to AD in MCI subjects (APOE ε4 non-carriers).

sMCI vs. pMCINC_early sMCI vs. pMCINC (all)
Accuracy (CI) Sensitivity (CI) Specificity (CI) McNemar test Accuracy (CI) Sensitivity (CI) Specificity (CI) McNemar test
Error rate (CI) χ2 Error rate (CI) χ2
BrainAGE score 0.78 (0.68–0.89) 0.71 (0.59–0.82) 0.83 (0.74–0.93) 0.22 (0.11–0.32) - 0.74 (0.64–0.84) 0.65 (0.54–0.76) 0.83 (0.75–0.92) 0.26 (0.16–0.36) -
Chronological age 0.50 (0.37–0.63) 0.83 (0.74–0.93) 0.31 (0.19–0.42) 0.50 (0.37–0.63) 8.53 (p < 0.01) 0.47 (0.36–0.59) 0.15 (0.07–0.23) 0.97 (0.93–1.00) 0.53 (0.41–0.64) 6.81 (p < 0.01)
MMSE score 0.60 (0.48–0.72) 0.79 (0.69–0.89) 0.58 (0.46–0.71) 0.40 (0.28–0.52) 4.17 (p < 0.05) 0.47 (0.36–0.59) 0.78 (0.68–0.87) 0.58 (0.47–0.69) 0.53 (0.41–0.64) 9.00 (p < 0.01)
CDR-SB score 0.67 (0.55–0.79) 0.58 (0.46–0.71) 0.75 (0.64–0.86) 0.33 (0.21–0.45) 1.64 (n.s.) 0.51 (0.40–0.63) 0.53 (0.41–0.64) 0.75 (0.65–0.85) 0.49 (0.37–0.60) 8.53 (p < 0.01)
ADAS score 0.68 (0.57–0.80) 0.92 (0.85–0.99) 0.58 (0.46–0.71) 0.32 (0.20–0.43) 0.93 (n.s.) 0.64 (0.54–0.75) 0.90 (0.83–0.97) 0.58 (0.47–0.69) 0.36 (0.25–0.46) 1.20 (n.s.)

Bold type = significant; n.s. = not significant